About Astarte Medical
Astarte Medical is the first microbial health informatics company focused on improving health outcomes during the first thousand days of life. Astarte’s first product platform, NICUtrition™, leverages clinical data to standardize enteral feeding, optimize nutrition, and quantify and monitor gut health within the neonatal intensive care unit.
Learn more about NICUtrition™ - watch our video
First 1000 Days
Research has shown that the first 1000 days of life from conception to age 2 are the most important and vulnerable days for the growth of the microbiome. Declining microbiome health has resulted in higher rates of chronic and neurological diseases including obesity, autism, IBD, and more.
Astarte is leveraging our innovative software solutions to diagnose and treat gut health faster and more effectively. The highest level of care is essential for these young patients with extremely vulnerable microbiomes.
Leadership
Tracy Warren
CEOA serial entrepreneur, early stage and angel investor in health care for over 15 years. Tracy is the co-inventor of NICUtrition and drives the organization to make a meaningful difference in the lives of our most precious at-risk babies.
Twitter: @TracyAstarte
Linked In: View Profie
Tammi Jantzen
COO/CFOKauffman Fellow and CPA who has worked alongside both founders and investors to construct the backbone of groundbreaking companies with an interest in helping women balance family, health and career.
Twitter: @Jantzentammi
Linked In: View Profie
Jeff Sherman
CTOA global IT management and business intelligence executive with over 20 years of experience for implementation and application with large, multinational clients, with a specialty in BI and analytic solutions. Jeff is leading development efforts, pilot deployments, and technical resources to grow the business.
Twitter: @BJeffreySherman
LinkedIn: view profile
Katherine Gregory
Scientific FounderA nurse scientist at Brigham & Women's Hospital, with clinical expertise in newborn intensive care nursing. Her research is focused on preterm infant gut health, specifically on acquisition of the intestinal microbiome following preterm birth. Published widely on necrotizing enterocolitis (NEC), a disease of the preterm infant gut and the role of nutrition, specifically human milk, in preterm infant health.
Twitter: @bostonbabybiome
LinkedIn: view profile
News
XLerateHealth Accelerator Selects Ten Healthcare Companies for Incoming Sixth Cohort (Read Story)
Venture capitalists address NICU needs (Read Story)
Keiretsu Forum Northwest Announces Astarte Medical Partners the Winner of Its “Most Valued Company" Award (Read Story)
PULSE@MassChallenge Announces 2018 Cohort of Top Digital Health Startups (Read Story)
5 Ways Johnson & Johnson Helps Keep the Littlest Patients Safe Around the World (Read Story)
Astarte Medical Wins JLABS Bugs, Drugs & Beyond Quickfire Challenge (Read Story)
Class 20 Kauffman Fellow Tammi Jantzen writes for Entrepreneur about the road ahead for female founders (Read Story)
Astarte Medical Selected as 2017 MassChallenge Boston Finalist (Read Story)
NICUtrition™ Selected for Medical Capital Innovation Competition in Cleveland (Read Story)
Tammi Jantzen speaks to Entrepreneur about the perspective she's gained from switching from her role as a VC who had been investing in products focused on women and children, to where she is now: an entrepreneur working to raise money for her startup, Astarte Medical Partners. (Read Story)
Astarte Medical to Present at Impact Pediatric Health Competition during SxSW (Read Story)